These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5047424)

  • 1. Treatment of rapidly progressing prostatic carcinoma with estracyt.
    Lindberg B
    J Urol; 1972 Aug; 108(2):303-6. PubMed ID: 5047424
    [No Abstract]   [Full Text] [Related]  

  • 2. [Preliminary results of 10 patients with advanced prostatic neoplasm treated with estracyt].
    de Leval J; Petit R; Bouffioux C
    Acta Urol Belg; 1974 Jul; 42(3):326-35. PubMed ID: 4440596
    [No Abstract]   [Full Text] [Related]  

  • 3. Estracyt in hormone-resistant prostatic carcinoma.
    Szendröi Z; Könyves I; Szendi L; Eckhardt S; Hartay F
    Int Urol Nephrol; 1974; 6(2):101-10. PubMed ID: 4448622
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment with estramustine phosphate in advanced prostatic cancer].
    Klein D
    Wien Med Wochenschr; 1972 Jul; 122(30):458-60. PubMed ID: 4114990
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacoclinical study of oral estramustine phosphate (Estracyt) in advanced carcinoma of the prostate.
    Müntzing J; Shukla SK; Chu TM; Mittelman A; Murphy GP
    Invest Urol; 1974 Jul; 12(1):65-8. PubMed ID: 4835492
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of prostatic carcinoma with orally administered Estracyt].
    Mayer EJ
    Ther Umsch; 1975 Feb; 32(2):114-9. PubMed ID: 1118820
    [No Abstract]   [Full Text] [Related]  

  • 7. Recent data on the mechanism of action of oestrogens in the treatment of prostatic tumour patients.
    Szendröi Z; Kocsár L; Karika Z; Füzi M; Tarján G; Reischel G; Eckhardt S
    Int Urol Nephrol; 1974; 5(3):311-23. PubMed ID: 4829136
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cytostatic treatment of prostatic carcinoma. Evaluation study of estramustinphosphate].
    Anderes A; Arquint A; Camponovo F; Deppeler O; Doerig R; Heim H; Humbert-Droz P; Jung HP; Magaro L; Sasso M; Vischer C; Wanner J; Wegmann HJ; Ziegler E
    Schweiz Rundsch Med Prax; 1971 Sep; 60(38):1276-9. PubMed ID: 5094915
    [No Abstract]   [Full Text] [Related]  

  • 9. Stage D prostatic carcinoma. Survival rate in relapsed patients following new forms of palliation.
    Welvaart K; Merrin CE; Mittelman A; Murphy GP
    Urology; 1974 Sep; 4(3):283-6. PubMed ID: 4138219
    [No Abstract]   [Full Text] [Related]  

  • 10. "Estracyt".
    Jönsson G
    Br J Urol; 1971 Dec; 43(6):732. PubMed ID: 5159576
    [No Abstract]   [Full Text] [Related]  

  • 11. Proceedings: Cancer of the prostate.
    Murphy GP
    Cancer; 1973 Nov; 32(5):1089-91. PubMed ID: 4127978
    [No Abstract]   [Full Text] [Related]  

  • 12. Estracyt (NSC 89199) as a substrate for phosphatases in human serum.
    Tritsch GL; Shukla SK; Mittelman A; Murphy GP
    Invest Urol; 1974 Jul; 12(1):38-9. PubMed ID: 4366126
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experiences with estramustinphosphate (Estracyt) in estrogen-resistant metastasizing prostatic cancer].
    Köller A; Lunglmayr G
    Wien Med Wochenschr; 1983; 133(7):179-81. PubMed ID: 6868629
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of previous treatment on Estracyt response in advanced stage D prostatic carcinoma.
    Mittelman A
    Urology; 1984 Jun; 23(6 Suppl):78-80. PubMed ID: 6730142
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of advanced carcinoma of the prostate with Estracyt (author's transl)].
    Nagel R; Kölln CP
    Med Klin; 1976 Oct; 71(41):1724-8. PubMed ID: 824540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of advanced carcinoma of the prostate with Estracyt.
    Nagel R; Kölln CP
    Prog Clin Biol Res; 1976; 6():267-84. PubMed ID: 1023214
    [No Abstract]   [Full Text] [Related]  

  • 17. [Estracyt treatment in prostatic neoplasms].
    Sander S
    Tidsskr Nor Laegeforen; 1976 Jan; 96(1):27-8. PubMed ID: 1257949
    [No Abstract]   [Full Text] [Related]  

  • 18. [Serum testosterone and acid phosphatase levels in patients with prostatic cancer treated with Estracyt].
    Németh A; Morvay J; Vécsei B
    Orv Hetil; 1981 Apr; 122(17):1017-20. PubMed ID: 7022313
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of hormone-resistant prostate cancer with estramustine phosphate (Estracyt)].
    Stridsklev IC; Fosså SD; Kaalhus O
    Tidsskr Nor Laegeforen; 1984 Oct; 104(28):1977-80. PubMed ID: 6388019
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of prostatic carcinoma with estramustine phosphate (Estracyt).
    Benson RC
    Wis Med J; 1976 Sep; 75(9):S89-90. PubMed ID: 969557
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.